These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 23880784
21. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome. Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Rabasco C, Espinosa M, Cavero T, Blasco M, Cao M, Manrique J, Cabello-Chavez V, Suñer M, Heras M, Fulladosa X, Belmar L, Sempere A, Peralta C, Castillo L, Arnau A, Praga M, Rodriguez de Cordoba S. Kidney Int; 2018 Feb; 93(2):450-459. PubMed ID: 28911789 [Abstract] [Full Text] [Related]
22. CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome. Sugawara Y, Kato H, Nagasaki M, Yoshida Y, Fujisawa M, Minegishi N, Yamamoto M, Nangaku M. J Hum Genet; 2023 Jun; 68(6):427-430. PubMed ID: 36755127 [Abstract] [Full Text] [Related]
23. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS. Grenda R, Jarmużek W, Rubik J, Prokurat S, Miklaszewska M, Drozdz D, Zachwieja K, Ardissino G, Hofer J. Pediatr Transplant; 2015 Sep; 19(6):E130-4. PubMed ID: 26087050 [Abstract] [Full Text] [Related]
24. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report. Xie L, Nester CM, Reed AI, Zhang Y, Smith RJ, Thomas CP. Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022 [Abstract] [Full Text] [Related]
25. Unraveling Structural Rearrangements of the CFH Gene Cluster in Atypical Hemolytic Uremic Syndrome Patients Using Molecular Combing and Long-Fragment Targeted Sequencing. Tschernoster N, Erger F, Walsh PR, McNicholas B, Fistrek M, Habbig S, Schumacher AL, Folz-Donahue K, Kukat C, Toliat MR, Becker C, Thiele H, Kavanagh D, Nürnberg P, Beck BB, Altmüller J. J Mol Diagn; 2022 Jun; 24(6):619-631. PubMed ID: 35398599 [Abstract] [Full Text] [Related]
26. Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479. Chaudhary P, Hepgur M, Sarkissian S, Smith RJ, Weitz IC. Blood Transfus; 2014 Jan; 12(1):111-3. PubMed ID: 24333077 [No Abstract] [Full Text] [Related]
27. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. Dragon-Durey MA, Blanc C, Marliot F, Loirat C, Blouin J, Sautes-Fridman C, Fridman WH, Frémeaux-Bacchi V. J Med Genet; 2009 Jul; 46(7):447-50. PubMed ID: 19435718 [Abstract] [Full Text] [Related]
28. A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome. Maga TK, Meyer NC, Belsha C, Nishimura CJ, Zhang Y, Smith RJ. Nephrol Dial Transplant; 2011 Feb; 26(2):739-41. PubMed ID: 20974643 [Abstract] [Full Text] [Related]
29. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report. Vondrák K, Seeman T. Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469 [Abstract] [Full Text] [Related]
30. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies. Boyer O, Balzamo E, Charbit M, Biebuyck-Gougé N, Salomon R, Dragon-Durey MA, Frémeaux-Bacchi V, Niaudet P. Am J Kidney Dis; 2010 May; 55(5):923-7. PubMed ID: 20202729 [Abstract] [Full Text] [Related]
31. Atypical hemolytic uremic syndrome due to factor H autoantibody. Uslu-Gökceoğlu A, Doğan CS, Comak E, Koyun M, Akman S. Turk J Pediatr; 2013 May; 55(1):86-9. PubMed ID: 23692839 [Abstract] [Full Text] [Related]
32. Three months interval therapy of Eculizumab in a patient with atypical hemolytic uremic syndrome with hybrid CFHR1/CFH gene. Alobaidi S, AlDabbagh A, Alamoudi A, Almowarey M, Akl A. CEN Case Rep; 2019 May; 8(2):139-143. PubMed ID: 30715674 [Abstract] [Full Text] [Related]
33. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding. Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L. Pediatr Nephrol; 2012 Sep; 27(9):1519-24. PubMed ID: 22669319 [Abstract] [Full Text] [Related]
34. Successful treatment of DEAP-HUS with eculizumab. Noone D, Waters A, Pluthero FG, Geary DF, Kirschfink M, Zipfel PF, Licht C. Pediatr Nephrol; 2014 May; 29(5):841-51. PubMed ID: 24249282 [Abstract] [Full Text] [Related]
35. Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation. Kim S, Park E, Min SI, Yi NJ, Ha J, Ha IS, Cheong HI, Kang HG. J Korean Med Sci; 2018 Jan 01; 33(1):e4. PubMed ID: 29215813 [Abstract] [Full Text] [Related]
36. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation. Tran H, Chaudhuri A, Concepcion W, Grimm PC. Pediatr Nephrol; 2014 Mar 01; 29(3):477-80. PubMed ID: 24221349 [Abstract] [Full Text] [Related]
37. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Heinen S, Sanchez-Corral P, Jackson MS, Strain L, Goodship JA, Kemp EJ, Skerka C, Jokiranta TS, Meyers K, Wagner E, Robitaille P, Esparza-Gordillo J, Rodriguez de Cordoba S, Zipfel PF, Goodship TH. Hum Mutat; 2006 Mar 01; 27(3):292-3. PubMed ID: 16470555 [Abstract] [Full Text] [Related]
38. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system]. Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C. Rev Med Interne; 2011 Apr 01; 32(4):232-40. PubMed ID: 21376430 [Abstract] [Full Text] [Related]
39. Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case Report. Dedhia P, Govil A, Mogilishetty G, Alloway RR, Woodle ES, Abu Jawdeh BG. Transplant Proc; 2017 Apr 01; 49(1):188-192. PubMed ID: 28104134 [Abstract] [Full Text] [Related]
40. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G. Clin J Am Soc Nephrol; 2010 Oct 01; 5(10):1844-59. PubMed ID: 20595690 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]